NCT04194918

Brief Summary

This phase I trial studies how well Flexiquit+ helps young adult smokers who identify as a sexual and/or gender minority to quit or cut down on smoking. Flexiquit+ is an avatar-led, web-based intervention that can help smokers quit or cut back on how much they smoke cigarettes and/or vape, reducing their chances of developing tobacco-related health conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started May 2020

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 11, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

May 18, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

October 5, 2020

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

December 9, 2019

Last Update Submit

October 2, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Treatment utilization

    Will be determined by the server-recorded number of logins and the number of sessions completed. Frequencies (for categorical variables) or means and standard deviations (for continuous variables) will be reported for treatment utilization and satisfaction. Tables with N (%) or mean (standard deviation) by treatment arm will be provided.

    Enrollment up to 2 months

  • Treatment satisfaction: survey

    Will be determined using 12 items on the 2-month outcome survey. Frequencies (for categorical variables) or means and standard deviations (for continuous variables) will be reported for treatment utilization and satisfaction. Categorical ratings for treatment satisfaction questions will be dichotomized as "somewhat", "mostly", or "very" useful versus (vs.) lower ratings. Tables with N (%) or mean (standard deviation) by treatment arm will be provided.

    Enrollment up to 2 months

Secondary Outcomes (2)

  • Smoking cessation rate

    At 2 months post-enrollment

  • Change in motivation to quit smoking

    From baseline to 2-month follow-up

Study Arms (1)

Prevention (Flexiquit+, text message, handout)

EXPERIMENTAL

Individuals will be recruited to use the Flexiquit+ program consisting of 6 sessions, each lasting approximately 25 minutes. Participants will also receive text messages providing motivational messages and review information discussed in the program. At the end of the intervention, participants will receive an email with all of the session handouts.

Behavioral: Computer-Assisted Smoking Cessation InterventionOther: Text MessageOther: HandoutOther: Questionnaire AdministrationOther: Quality-of-Life AssessmentOther: Survey Administration

Interventions

Use the Flexiquit+ program

Prevention (Flexiquit+, text message, handout)

Receive text messages

Also known as: SMS Text, SMS Text Message, Text
Prevention (Flexiquit+, text message, handout)
HandoutOTHER

Receive handouts via email

Prevention (Flexiquit+, text message, handout)

Ancillary studies

Prevention (Flexiquit+, text message, handout)

Ancillary studies

Also known as: Quality of Life Assessment
Prevention (Flexiquit+, text message, handout)

Ancillary studies

Prevention (Flexiquit+, text message, handout)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants must self-identify as a sexual and/or gender minority (i.e., a sexual orientation other than straight and/or gender that doesn't match sex assigned at birth)
  • Participants must currently reside in the United States and anticipate remaining in the United States for the duration of the study (2 months)
  • Participants must self-report smoking at least 1 cigarette per day in the 30 days prior to screening
  • Participants must self-report having at least weekly internet access for the next two months
  • Participants must self-report being willing and able to stream video online for this study
  • Participants must self-report current use of a personal email account
  • Participants must self-report current use of text messaging
  • Participants must self-report that they are interested in participating in the study for themselves (versus \[vs\] someone else)
  • Participants must self-report that they are not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
  • Participants must self-report that they have not participated in one of our prior smoking cessation studies, including the user-centered research conducted in the development of Flexiquit+
  • Participants must self-report that they are comfortable reading, writing, and speaking English
  • Participants must self-report that they understand and agree to the conditions of compensation
  • Participants must self-report that they are not currently incarcerated in a prison
  • Participants must be willing to use the Flexiquit+ program, complete the study assessments, and sign an online consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

Location

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

Communication Devices for People with Disabilities

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Self-Help DevicesEquipment and Supplies

Study Officials

  • Jaimee Heffner

    Fred Hutch/University of Washington Cancer Consortium

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2019

First Posted

December 11, 2019

Study Start

May 18, 2020

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

October 5, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations